• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探究癌症中的 T 细胞免疫:成就与展望。

Investigating T Cell Immunity in Cancer: Achievements and Prospects.

机构信息

Diamantina Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4102, Australia.

出版信息

Int J Mol Sci. 2021 Mar 12;22(6):2907. doi: 10.3390/ijms22062907.

DOI:10.3390/ijms22062907
PMID:33809369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7999898/
Abstract

T cells play a key role in tumour surveillance, both identifying and eliminating transformed cells. However, as tumours become established they form their own suppressive microenvironments capable of shutting down T cell function, and allowing tumours to persist and grow. To further understand the tumour microenvironment, including the interplay between different immune cells and their role in anti-tumour immune responses, a number of studies from mouse models to clinical trials have been performed. In this review, we examine mechanisms utilized by tumour cells to reduce their visibility to CD8 Cytotoxic T lymphocytes (CTL), as well as therapeutic strategies trialled to overcome these tumour-evasion mechanisms. Next, we summarize recent advances in approaches to enhance CAR T cell activity and persistence over the past 10 years, including bispecific CAR T cell design and early evidence of efficacy. Lastly, we examine mechanisms of T cell infiltration and tumour regression, and discuss the strengths and weaknesses of different strategies to investigate T cell function in murine tumour models.

摘要

T 细胞在肿瘤监测中发挥着关键作用,既能识别又能消除转化细胞。然而,随着肿瘤的建立,它们会形成自己的抑制性微环境,能够关闭 T 细胞的功能,从而使肿瘤得以持续生长。为了进一步了解肿瘤微环境,包括不同免疫细胞之间的相互作用及其在抗肿瘤免疫反应中的作用,已经进行了许多从小鼠模型到临床试验的研究。在这篇综述中,我们研究了肿瘤细胞用来降低其对 CD8 细胞毒性 T 淋巴细胞(CTL)可见性的机制,以及为克服这些肿瘤逃逸机制而尝试的治疗策略。接下来,我们总结了过去 10 年来增强嵌合抗原受体 T 细胞(CAR T 细胞)活性和持久性的最新进展,包括双特异性 CAR T 细胞设计和早期疗效证据。最后,我们研究了 T 细胞浸润和肿瘤消退的机制,并讨论了在小鼠肿瘤模型中研究 T 细胞功能的不同策略的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/816d/7999898/3e72dee4e477/ijms-22-02907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/816d/7999898/4a19e37f774d/ijms-22-02907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/816d/7999898/3e72dee4e477/ijms-22-02907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/816d/7999898/4a19e37f774d/ijms-22-02907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/816d/7999898/3e72dee4e477/ijms-22-02907-g002.jpg

相似文献

1
Investigating T Cell Immunity in Cancer: Achievements and Prospects.探究癌症中的 T 细胞免疫:成就与展望。
Int J Mol Sci. 2021 Mar 12;22(6):2907. doi: 10.3390/ijms22062907.
2
Cytotoxic CD8 Lymphocytes in the Tumor Microenvironment.肿瘤微环境中的细胞毒性 CD8+淋巴细胞。
Adv Exp Med Biol. 2020;1224:53-62. doi: 10.1007/978-3-030-35723-8_4.
3
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.基于痘病毒的主动免疫疗法与CTLA-4阻断协同作用,通过提高细胞毒性T细胞的数量和质量来提高小鼠肿瘤模型的生存率。
Cancer Immunol Immunother. 2016 May;65(5):537-49. doi: 10.1007/s00262-016-1816-7. Epub 2016 Mar 10.
4
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.免疫肿瘤学:了解免疫系统在癌症中的功能和失调。
Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii6-9. doi: 10.1093/annonc/mds256.
5
Macrophage-Mediated Subversion of Anti-Tumour Immunity.巨噬细胞介导的抗肿瘤免疫逃逸。
Cells. 2019 Jul 19;8(7):747. doi: 10.3390/cells8070747.
6
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
7
Enhancing tumor T cell infiltration to enable cancer immunotherapy.增强肿瘤 T 细胞浸润以实现癌症免疫治疗。
Immunotherapy. 2019 Feb;11(3):201-213. doi: 10.2217/imt-2018-0111.
8
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.免疫检查点 Ab 通过调节树突状细胞和调节性 T 淋巴细胞增强了抗原特异性抗肿瘤作用。
Cancer Lett. 2019 Mar 1;444:20-34. doi: 10.1016/j.canlet.2018.11.039. Epub 2018 Dec 10.
9
Chimeric Antigen Receptors for the Tumour Microenvironment.嵌合抗原受体靶向肿瘤微环境
Adv Exp Med Biol. 2020;1263:117-143. doi: 10.1007/978-3-030-44518-8_8.
10
Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling.肿瘤内在致癌信号对免疫微环境的调节。
J Cell Biol. 2020 Jan 6;219(1). doi: 10.1083/jcb.201908224.

引用本文的文献

1
GNGT1 is a potential prognostic and immunologic biomarker in gastric cancer.GNGT1是胃癌中一种潜在的预后和免疫生物标志物。
Sci Rep. 2025 Jul 1;15(1):21149. doi: 10.1038/s41598-025-08297-4.
2
Endoplasmic Reticulum Stress in Cancer.癌症中的内质网应激
MedComm (2020). 2025 Jun 19;6(7):e70263. doi: 10.1002/mco2.70263. eCollection 2025 Jul.
3
Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment.揭开cGAS-STING通路的神秘面纱:肿瘤免疫微环境中的精准调控

本文引用的文献

1
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives.肿瘤内皮细胞(TECs)作为肿瘤微环境潜在的免疫导向细胞——新发现与未来展望
Front Cell Dev Biol. 2020 Aug 19;8:766. doi: 10.3389/fcell.2020.00766. eCollection 2020.
2
Targeting STAT3 in Cancer Immunotherapy.靶向 STAT3 在癌症免疫治疗中的作用。
Mol Cancer. 2020 Sep 24;19(1):145. doi: 10.1186/s12943-020-01258-7.
3
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer.转移性肾细胞癌免疫治疗反应的预测生物标志物
Mol Cancer. 2025 Jun 12;24(1):178. doi: 10.1186/s12943-025-02380-0.
4
Harnessing Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Opportunities and Barriers to Clinical Integration.利用三阴性乳腺癌中的肿瘤浸润淋巴细胞:临床整合的机遇与障碍
Int J Mol Sci. 2025 May 1;26(9):4292. doi: 10.3390/ijms26094292.
5
Clinical characteristics and risk factors of late-stage lung adenocarcinoma patients with bacterial pulmonary infection and its relationship with cellular immune function.晚期肺腺癌合并细菌性肺部感染患者的临床特征、危险因素及其与细胞免疫功能的关系
Front Immunol. 2025 Apr 16;16:1559211. doi: 10.3389/fimmu.2025.1559211. eCollection 2025.
6
Overexpression and clinicopathological significance of zinc finger protein 71 in hepatocellular carcinoma.锌指蛋白71在肝细胞癌中的过表达及临床病理意义
World J Hepatol. 2025 Feb 27;17(2):101914. doi: 10.4254/wjh.v17.i2.101914.
7
Nomogram-derived immune-inflammation-nutrition score could act as a novel prognostic indicator for patients with head and neck squamous cell carcinoma.基于列线图的免疫炎症营养评分可作为头颈部鳞状细胞癌患者的一种新型预后指标。
Front Immunol. 2025 Jan 14;15:1500525. doi: 10.3389/fimmu.2024.1500525. eCollection 2024.
8
Modeling immune checkpoint inhibitor associated myocarditis and its therapeutic implications.免疫检查点抑制剂相关心肌炎的建模及其治疗意义。
J Mol Cell Cardiol Plus. 2024 Dec;10. doi: 10.1016/j.jmccpl.2024.100122. Epub 2024 Nov 20.
9
RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints.癌症免疫治疗中的 RNA 修饰:免疫细胞和免疫检查点的调节剂。
Front Immunol. 2024 Sep 20;15:1463847. doi: 10.3389/fimmu.2024.1463847. eCollection 2024.
10
Assessing a single-cell multi-omic analytic platform to characterize -engineered T-cell therapy products.评估一种单细胞多组学分析平台以表征工程化T细胞治疗产品。
Front Bioeng Biotechnol. 2024 Aug 20;12:1417070. doi: 10.3389/fbioe.2024.1417070. eCollection 2024.
Front Oncol. 2020 Aug 12;10:1644. doi: 10.3389/fonc.2020.01644. eCollection 2020.
4
Prognostic significance of spatial immune profiles in human solid cancers.空间免疫图谱在人类实体瘤中的预后意义。
Cancer Sci. 2020 Oct;111(10):3426-3434. doi: 10.1111/cas.14591. Epub 2020 Aug 12.
5
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.肿瘤微环境中的调节性 T 细胞:新机制、潜在治疗策略和未来前景。
Mol Cancer. 2020 Jul 17;19(1):116. doi: 10.1186/s12943-020-01234-1.
6
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.癌症中MHC I类分子下调:潜在机制及癌症免疫治疗的潜在靶点
Cancers (Basel). 2020 Jul 2;12(7):1760. doi: 10.3390/cancers12071760.
7
Mouse Tumor Models for Advanced Cancer Immunotherapy.用于高级癌症免疫疗法的小鼠肿瘤模型。
Int J Mol Sci. 2020 Jun 9;21(11):4118. doi: 10.3390/ijms21114118.
8
γδ T Cells: The Ideal Tool for Cancer Immunotherapy.γδ T 细胞:癌症免疫疗法的理想工具。
Cells. 2020 May 24;9(5):1305. doi: 10.3390/cells9051305.
9
Metabolic alterations in the tumor microenvironment and their role in oncogenesis.肿瘤微环境中的代谢改变及其在肿瘤发生中的作用。
Cancer Lett. 2020 Aug 1;484:65-71. doi: 10.1016/j.canlet.2020.04.016. Epub 2020 May 6.
10
Mouse Models for Immunotherapy in Hepatocellular Carcinoma.肝细胞癌免疫治疗的小鼠模型
Cancers (Basel). 2019 Nov 15;11(11):1800. doi: 10.3390/cancers11111800.